{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:42:58Z","timestamp":1790379778193,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Castilla Le\u00f3n Regional Health Authority"},{"name":"Gerencia Regional de Salud de Castilla y Le\u00f3n","award":["INT\/M\/17\/17"],"award-info":[{"award-number":["INT\/M\/17\/17"]}]},{"name":"Gerencia Regional de Salud de Castilla y Le\u00f3n","award":["INT\/M\/06\/18"],"award-info":[{"award-number":["INT\/M\/06\/18"]}]},{"name":"Institute of Biomedical Research of Salamanca-IBSAL","award":["II14\/0006"],"award-info":[{"award-number":["II14\/0006"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.autrev.2020.102490","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T02:36:18Z","timestamp":1581561378000},"page":"102490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Rituximab treatment for IgA vasculitis: A systematic review"],"prefix":"10.1016","volume":"19","author":[{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-A","family":"Mir\u00f3n-Canelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Diez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102490_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102490_bb0010","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data from 260 patients included in a French multicenter retrospective survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-018-0735-3","article-title":"IgA vasculitis: genetics and clinical and therapeutic management","volume":"20","author":"Gonz\u00e1lez-Gay","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2020.102490_bb0020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2340\/00015555-2733","article-title":"Henoch-Schonlein purpura: a literature review","volume":"97","author":"Hetland","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2020.102490_bb0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch\u2013Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102490_bb0030","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Schonlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102490_bb0035","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102490_bb0040","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2005.10.011","article-title":"Henoch-Schonlein purpura associated with malignancy in adults","volume":"55","author":"Zurada","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0045","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin a vasculitis-the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102490_bb0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/art.1780330809","article-title":"The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura","volume":"33","author":"Mills","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102490_bb0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102490_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-016-0100-x","article-title":"Azathioprine therapy for steroid-resistant Henoch-Schonlein purpura: a report of 6 cases","volume":"14","author":"Fotis","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.autrev.2020.102490_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0b013e32833af608","article-title":"Henoch-Schonlein purpura","volume":"22","author":"Saulsbury","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.clml.2018.05.009","article-title":"An evidence-based review of anti-CD20 antibody-containing regimens for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia, diffuse large B-cell lymphoma, or follicular lymphoma","volume":"18","author":"Falchi","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.autrev.2020.102490_bb0075","article-title":"Treatment for refractory lupus nephritis: rituximab vs triple target therapy","volume":"102406","author":"Cervera","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102490_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2017-212768","article-title":"Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides","volume":"77","author":"Terrier","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102490_bb0085","article-title":"New insights in cryoglobulinemic vasculitis","volume":"102313","author":"Silva","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102490_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","article-title":"Brief report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schonlein)","volume":"70","author":"Maritati","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12969-018-0285-2","article-title":"Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature","volume":"16","author":"Crayne","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.autrev.2020.102490_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","article-title":"Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature","volume":"65","author":"Fenoglio","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102490_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2008.12.049","article-title":"Rituximab therapy for severe refractory chronic Henoch-Schonlein purpura","volume":"155","author":"Donnithorne","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2020.102490_bb0110","first-page":"20","article-title":"B cell depleting therapy with rituximab or ofatumumab in immunoglobulin a nephropathy or vasculitis with nephritis","volume":"10","author":"Lundberg","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2020.102490_bb0115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archderm.142.11.1407","article-title":"Successful use of rituximab for cutaneous vasculitis","volume":"142","author":"Chung","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0120","first-page":"327","article-title":"Falling through the cracks of vasculitis classification - a report of three patients","volume":"4","author":"Havill","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.autrev.2020.102490_bb0125","first-page":"306","article-title":"Successful treatment of intractable gastrointestinal bleeding in Henoch-Schonlein purpura with rituximab: first reported case","volume":"57","author":"Wright","year":"2009","journal-title":"J Invest Med"},{"key":"10.1016\/j.autrev.2020.102490_bb0130","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfr137","article-title":"Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report","volume":"26","author":"Pillebout","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102490_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pedneo.2011.08.009","article-title":"Henoch-Sch\u00f6nlein purpura and elevated hepatitis C virus antibody in a girl with nasopharyngeal diffuse large B-cell lymphoma","volume":"52","author":"Hou","year":"2011","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0140","first-page":"559","article-title":"Case report: overlapping of henoch schonlein purpura and microscopic polyangiitis","volume":"96","author":"Cerda","year":"2012","journal-title":"Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102490_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1755-6686.2013.12007.x","article-title":"Refractory Henoch-Sch\u00f6nlein purpura: atypical aetiology and management","volume":"39","author":"El-Husseini","year":"2013","journal-title":"J Ren Care"},{"key":"10.1016\/j.autrev.2020.102490_bb0150","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2169\/internalmedicine.52.9325","article-title":"Rituximab treatment for adult purpura nephritis with nephrotic syndrome","volume":"52","author":"Ishiguro","year":"2013","journal-title":"Intern Med"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2020.102490_bb0155","first-page":"682","article-title":"Has rituximab (RTX) a role in treatment of chronic non-renal Henoch-Schonlein purpura (HSP)? 9 years follow up of a patient with severe gastro-intestinal disease","volume":"71","author":"Tosounidou","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102490_bb0160","doi-asserted-by":"crossref","first-page":"619218","DOI":"10.1155\/2014\/619218","article-title":"Successful outcome of a corticodependent Henoch-Schonlein purpura adult with rituximab","volume":"2014","author":"Pindi Sala","year":"2014","journal-title":"Case Rep Med"},{"issue":"Suppl","key":"10.1016\/j.autrev.2020.102490_bb0165","doi-asserted-by":"crossref","first-page":"203A","DOI":"10.1378\/chest.1993431","article-title":"Diffuse alveolar hemorrhage: a rare complication of Henoch-Schonlein purpura successfully treated with rituximab","volume":"146","author":"Abdo","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2020.102490_bb0170","first-page":"S243","article-title":"Resolution of sinus bradycardia, complete heart block and left ventricular dysfunction with rituximab therapy in Henoch-Schonlein purpura","volume":"1","author":"Balulad","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.autrev.2020.102490_bb0175","first-page":"269895","article-title":"Long-term therapeutic plasma exchange to prevent end-stage kidney disease in adult severe resistant Henoch-Schonlein purpura nephritis","volume":"2015","author":"Hamilton","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.autrev.2020.102490_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/03009742.2015.1058417","article-title":"Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Sch\u00f6nlein purpura with rituximab","volume":"45","author":"Bellan","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102490_bb0185","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/rheumatology\/kew286","article-title":"Successful outcome using bortezomib in adult refractory IgA vasculitis: a case report","volume":"55","author":"Van De Perre","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102490_bb0190","first-page":"1749","article-title":"Recurrent Henoch-Schonlein purpura with severe complications: a case report","volume":"32","author":"Staude","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2020.102490_bb0195","doi-asserted-by":"crossref","first-page":"AB213","DOI":"10.1016\/j.jaci.2016.12.691","article-title":"Long-lasting remission of severe refractory Henoch-Schonlein purpura nephritis with rituximab","volume":"139","author":"Yeh","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102490_bb0200","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1681\/ASN.2016060640","article-title":"A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction","volume":"28","author":"Lafayette","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:55Z","timestamp":1761599875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220300380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1568997220300380"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102490","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab treatment for IgA vasculitis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102490"}}